Clinical Trial Update: Basic Documentation of Adalimumab (Humira) in Patients With Ankylosing Spondylitis (AS)

View source ↗

Summary

This clinical trial update documents basic documentation for adalimumab (Humira) in patients with Ankylosing Spondylitis. The trial results were posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis

Drugs mentioned

• Humira (adalimumab)

Snippet

Sponsor: AbbVie (prior sponsor, Abbott) | Conditions: Ankylosing Spondylitis | Status: COMPLETED | Results posted: 2015-06-01